Preview Mode Links will not work in preview mode

This Week in Cardiology

May 5, 2023

Beta-blockers post MI, public perception of statins, trust in the medical profession, BMI, and TAVI are the topics John Mandrola, MD, covers in this week's podcast.

This podcast is intended for healthcare professionals only.

To read a partial transcript or to comment, visit:

I. Post-MI Beta Blockers

Long-term Beta-Blockers Not Needed After MI with Preserved Systolic Function?

- Association of beta-blockers beyond 1 year after myocardial infarction and cardiovascular outcomes

- Defibrillator Implantation in Patients with Nonischemic Systolic Heart Failure

II. Statin Perceptions

Statin Misinformation on Social Media Flagged by AI

- Artificial Intelligence–Enabled Analysis of Statin-Related Topics and Sentiments on Social Media


BMI Is a Flawed Measure of Obesity. What Are Alternatives?

IV. TAVI Access

Better Access to Transcatheter Aortic Valve Replacement Associated With Improved Outcomes

- Regional Differences in Outcomes for Patients Undergoing Transcatheter Aortic Valve Replacement in New York State and Ontario

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact: